Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Merck KGaA
DescriptionAnti-CD19 mAb
Molecular Target CD19
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationB cell lymphoma
Indication DetailsTreat advanced B cell lymphoma
Regulatory Designation
PartnerCancer Research Technology Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today